Skip to main content
Founding clinical partner

A UK TRT platform, in build. Looking for its founding clinical partner.

57 dashboard pages, 103 API endpoints, 63 data models, built. GMC prescriber, clinical co-founder, compliance signatory, wanted.

Solo technical founder, AI-augmented build. Bio below.

Email Chanikul
Founder note

I built TRT Platform because the operating layer should be a serious piece of software.

I came to TRT through people in my life on therapy, and through working alongside a prescriber managing several thousand TRT patients. I built TRT Platform because the operating layer of that practice — onboarding, lab integration, prescribing, monitoring, audit — should be a serious piece of software, and right now it isn’t. I’m a technical product founder; AI-augmented build, single operator. The platform exists. The clinical co-founder is the missing piece.

Signed: Chanikul · Founder.

Built today

A working clinical operating system, today.

Four role-based portals, live. Each card is a real surface in the platform, not a roadmap promise.

Doctor portal

29 pages

  • Command centre and patient list
  • Consultations with AI-structured notes
  • Treatment plans
  • Prescriptions (draft workflow)
  • Lab results with AI extraction and analysis, PENDING_REVIEW gated
  • TRT toolkit (dose, half-life, peak, injection scheduler)
  • Google Calendar sync, monthly reports

Patient portal

12 pages

  • Onboarding flow with consent capture
  • Appointments (book, reschedule, cancel)
  • Blood test PDF upload
  • Prescription refill request
  • Stripe checkout for invoices
  • Symptom and progress tracking
  • Deletion request (UK GDPR right-to-erasure)

Admin portal

12 pages

  • Analytics
  • Append-only audit logs
  • Compliance dashboard
  • Deletion-request processing
  • Doctors and staff management
  • Refill request decisions (prescriber-recorded)
  • Revenue dashboard with export, system health
Why this, why now

The current UK private TRT market runs on ad-hoc tooling.

NHS testosterone thresholds and capacity mean symptomatic men whose results fall in the borderline band are often left outside the treatment pathway; the private market that serves them runs on ad-hoc tooling, with no operator-grade software underneath the category.

Why platform-first matters. Multi-tenant from day one means a clinical lead’s practice runs on the same OS as the next clinic’s; every clinical decision carries a timestamped, attributable record in an append-only audit log, so inspection preparation stops being an archaeology project; AI-clinician handoff means scale without compromising the regulated bottleneck.

Honest framing. This is a market hypothesis, not a market analysis. The page does not claim to know the size; it claims to know the shape.

Regulatory roadmap
GMCprescriber, recruitingCQCservice, scopingGPhCpharmacy partner, recruitingMHRAreview at MVPICOregistered
Built for the regulated environment

Compliance architecture, not a compliance afterthought.

Audit

Prescribing, treatment-plan changes, appointments and AI reviews are written to an append-only audit log that the database refuses to edit or delete. Appointments also keep their own change history.

AI, bounded

AI is bounded. It is used for lab-result extraction and analysis and for consultation-note suggestions, and every AI output sits in PENDING_REVIEW until a clinician signs off. Working towards DCB0129: the clinical safety case and hazard log are in progress.

Architecture inventory
  • AuditLogappend-only (database-enforced)
  • AppointmentAuditEntrychange history
  • PrescriptionAuditEntryschema ready
  • TreatmentPlanAuditEntryschema ready
  • ClinicalHazardLogHistoryDCB0129 (schema ready)
  • DeletionRequestUK GDPR Article 17
  • PENDING_REVIEWAI clinician gate
  • Multi-tenant via Clinicapplication-enforced clinic isolation
The ask

A founding clinical partner.

Not looking for: hands-off advisors, equity-without-skin-in-the-game, or patient acquisition help (yet).

Primary

Clinical lead

GMC-registered prescriber. Will be named on regulatory submissions and act as the responsible person. Equity-led, scope flexible — full clinical co-founder through to advisor and signatory.

“This is the role that unlocks the platform’s launch.”

Email Chanikul

Compliance partner

CQC, MHRA, and GPhC experience. Can be combined with the clinical lead role or held separately.

“Especially welcome if you’ve taken a UK digital-health product through CQC registration before.”

Email Chanikul

Capital

Open to right partner. Angel, healthtech operator, or strategic.

“Capital-only conversations welcome but the clinical partner is the primary need.”

Email Chanikul
What partners ask

Diligence, in advance.

Seven questions a serious clinician, compliance partner, or investor tends to ask in the first email. Answered here so the email reply can be the second one.

  1. A working clinical operating system across four role-based portals. 57 dashboard pages, 103 API endpoints, 63 Prisma models. The Built today section above lists the visible surface; the architecture inventory in Compliance lists the audit and governance structures, and which are live versus schema-ready. Live demo by request, gated by an email reply so I can spend the time on serious enquiries.